293 related articles for article (PubMed ID: 11256799)
1. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.
von Eyben FE
Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
von Eyben FE
Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
[TBL] [Abstract][Full Text] [Related]
4. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
6. Laboratory markers and germ cell tumors.
von Eyben FE
Crit Rev Clin Lab Sci; 2003 Aug; 40(4):377-427. PubMed ID: 14582602
[TBL] [Abstract][Full Text] [Related]
7. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
[TBL] [Abstract][Full Text] [Related]
8. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
[TBL] [Abstract][Full Text] [Related]
9. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
10. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate dehydrogenase isoenzyme 1. An early indicator of relapse in patients with testicular germ cell tumors.
Edler von Eyben F; Lindegaard Madsen E; Blaabjerg O; Hyltoft Petersen P
Acta Oncol; 1995; 34(7):925-9. PubMed ID: 7492382
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
13. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract][Full Text] [Related]
14. Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors.
von Eyben FE; Skude G; Fosså SD; Klepp O; Børmer O
Mol Gen Genet; 1983; 189(2):326-33. PubMed ID: 6190072
[TBL] [Abstract][Full Text] [Related]
15. Serum lactate dehydrogenase isoenzyme 1 as predictor of tumor-associated death in patients with testicular germ cell tumours.
von Eyben FE; Lindegaard Madsen E
Andrologia; 1997; 29(3):137-40. PubMed ID: 9197917
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
17. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
18. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
19. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
[TBL] [Abstract][Full Text] [Related]
20. Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I.
von Eyben FE; Madsen EL; Blaabjerg O; Petersen PH; von der Maase H; Jacobsen GK; Rørth M
Acta Oncol; 2001; 40(4):536-40. PubMed ID: 11504315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]